- Home
- AKAM vs ARWR Comparison
AKAM vs ARWR Comparison
Compare AKAM & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKAM | ARWR |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.6B |
| IPO Year | 1999 | 1993 |
Fundamental Metrics
Financial Performance| Metric | AKAM | ARWR |
|---|---|---|
| Price | $86.89 | $68.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | ★ $94.67 | $60.70 |
| AVG Volume (30 Days) | ★ 3.7M | 3.3M |
| Earning Date | 11-06-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.97 | N/A |
| EPS | ★ 3.41 | N/A |
| Revenue | ★ $4,133,202,000.00 | $829,448,000.00 |
| Revenue This Year | $7.09 | N/A |
| Revenue Next Year | $5.26 | N/A |
| P/E Ratio | $25.16 | ★ N/A |
| Revenue Growth | 4.21 | ★ 23258.15 |
| 52 Week Low | $67.51 | $9.57 |
| 52 Week High | $103.75 | $72.36 |
Technical Indicators
Market Signals| Indicator | AKAM | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 55.99 | 72.80 |
| Support Level | $85.15 | $68.01 |
| Resistance Level | $87.27 | $72.36 |
| Average True Range (ATR) | 2.32 | 4.99 |
| MACD | -0.56 | 1.03 |
| Stochastic Oscillator | 55.09 | 86.66 |
Price Performance
Historical ComparisonAbout AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.